The Effect of Insulin Detemir in Combination With Liraglutide and Metformin Compared to Liraglutide and Metformin in Subjects With Type 2 Diabetes. A 26 Week, Randomised, Open-Label, Parallel-Group, Multicentre, Multinational Trial With a 26 Week Extension.
Phase of Trial: Phase III
Latest Information Update: 13 Mar 2017
At a glance
- Drugs Insulin detemir (Primary) ; Liraglutide (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Novo Nordisk
- 07 Jun 2017 Biomarkers information updated
- 21 Apr 2012 Planned patient number is 940 according to European Clinical Trials Database.
- 08 Dec 2011 Results presented at the 21st World Diabetes Congress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History